180 studies found for:    "Osteoporosis, Postmenopausal"
Show Display Options
Rank Status Study
21 Completed A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: Risedronate;   Drug: ibandronate [Bonviva/Boniva]
22 Completed A Study of Adherence to Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP).
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
23 Completed Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: disodium clodronate 200 mg/4 ml with 1% lidocaine;   Drug: Disodium clodronate 100 mg/3,3 ml with 1% lidocaine
24 Completed Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Bazedoxifene;   Drug: Placebo
25 Completed Risedronate Sodium in Post Menopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate sodium
26 Active, not recruiting Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 785;   Drug: Placebo
27 Completed Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Intervention: Drug: Teriparatide
28 Recruiting Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Liuwei Dihuang Pills
29 Active, not recruiting Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
Condition: Post-menopausal Osteoporosis
Interventions: Drug: Ibandronate;   Drug: Risedronate;   Drug: Alendronate
30 Completed Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
31 Completed Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women
Condition: Osteoporosis Postmenopausal
Intervention: Drug: Risedronate (HMR4003)
32 Active, not recruiting Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Bazedoxifene;   Drug: Calcium/Vit D
33 Recruiting Radius Loading in Primary Hyperparathyroidism
Conditions: Hyperparathyroidism, Primary;   Bone Diseases, Metabolic;   Osteoporosis, Postmenopausal;   Bone Loss, Postmenopausal
Interventions: Other: Forearm exercise program;   Other: Walking program
34 Completed MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
35 Completed A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Alendronate;   Drug: Risedronate 35 mg;   Dietary Supplement: Elemental Calcium;   Dietary Supplement: Vitamin D;   Drug: Risendronate placebo;   Drug: Alendronate placebo
36 Completed A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: alendronate;   Drug: ibandronate [Bonviva/Boniva]
37 Completed A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Zoledronic acid
38 Completed DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
39 Recruiting Wellnara Post-marketing Surveillance in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2/LNG oral (Wellnara, BAY86-5029)
40 Completed Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate (HMR4003)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years